SCHEMBL6406701

SCHEMBL6406701

CCCCCNC(CCC)c1cccc(O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 3/20 0.43
LMNA P02545 2/20 0.43
GALR3 O60755 1/20 0.43
ADRB2 P07550 4/20 0.42
ADRB1 P08588 1/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
ADRB3 P13945 1/20 0.42
TSHR P16473 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
NFKB1 P19838 1/20 0.42
DRD1 P21728 1/20 0.42
HTR7 P34969 1/20 0.42
ADRA1A P35348 1/20 0.42
ADRA1B P35368 1/20 0.42
DRD3 P35462 1/20 0.42
RAB9A P51151 1/20 0.42
SLC6A3 Q01959 1/20 0.42
SLC2A1 P11166 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16937753 0.77 HIF1A (0.46) HIF1ALMNAGALR3ADRB2ADRB1
SCHEMBL16937785 0.76 HIF1A (0.45) HIF1ALMNAGALR3ADRB2ADRB1
SCHEMBL6406697 0.76 HIF1A (0.45) HIF1ALMNAGALR3ADRB2ADRB1
SCHEMBL9620888 0.74 HIF1A (0.58) HIF1ALMNAGALR3ADRB2ADRB1
SCHEMBL11616756 0.74 OPRM1 (0.50) HIF1ALMNAGALR3ADRB2ADRB1
SCHEMBL27708071 0.74 SLC2A1 (0.43) SLC2A1
SCHEMBL27739296 0.74 DRD3 (0.43) HIF1ALMNAGALR3ADRB2ADRB1
SCHEMBL8400500 0.73 HIF1A (0.45) HIF1ALMNAGALR3ADRB2ADRB1
SCHEMBL27669180 0.73 DRD3 (0.46) HIF1ALMNAGALR3ADRB2ADRB1
SCHEMBL11616882 0.73 OPRM1 (0.51) HIF1ALMNAGALR3ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9090651-B2 Helix 12 directed pharmaceutical products ENDORECHERCHE, INC. (CA) 2015-07-28 US disclosed
US-20050250749-A1 Helix 12 directed pharmaceutical products ENDORECHERCHE, INC. 2005-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250749-A1 Helix 12 directed pharmaceutical products SHBG, AR, NR5A1 HIF1A 1891/4885LMNA 1763/4885GALR3 2992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.